Filing Details

Accession Number:
0001209191-18-016034
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-02 19:17:22
Reporting Period:
2018-02-28
Accepted Time:
2018-03-02 19:17:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1377121 Protagonist Therapeutics Inc PTGX Pharmaceutical Preparations (2834) 980505495
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1675881 Y David Liu C/O Protagonist Therapeutics, Inc.
7707 Gateway Blvd., Suite 140
Newark CA 94560-1160
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-28 9,500 $0.00 13,322 No 4 A Direct
Common Stock Acquisiton 2018-03-02 875 $1.89 14,197 No 4 M Direct
Common Stock Disposition 2018-03-02 875 $20.00 13,322 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Acquisiton 2018-02-28 56,500 $0.00 56,500 $16.95
Common Stock Employee Stock Option (right to buy) Disposition 2018-03-02 875 $0.00 875 $1.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
56,500 2028-02-27 No 4 A Direct
9,725 2024-10-22 No 4 M Direct
Footnotes
  1. Represents grant of the restricted stock units payable solely in common stock that vest in equal annual installments over four years from the grant date.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2017.
  3. The shares underlying this option shall vest as to 25% after one year following the grant date, and the remainder will vest in equal monthly installments over the following three years.
  4. The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.